SCHEMBL7657647

SCHEMBL7657647

O=C(O)c1ccc(N(C(=O)Cc2ccccc2)C(=O)Cc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 3/20 0.54
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
CES2 O00748 2/20 0.45
CES1 P23141 2/20 0.45
AKR1B1 P15121 1/20 0.45
REN P00797 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TAS2R14 Q9NYV8 1/20 0.45
TSHR P16473 3/20 0.45
DAO P14920 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
HSD17B10 Q99714 1/20 0.45
PTGES O14684 1/20 0.44
ALOX5 P09917 1/20 0.44
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21085193 0.84 FNTA (0.58) CES2CES1AKR1B1RENALOX5
SCHEMBL7657322 0.83 KMT2A (0.53) RENMEN1KMT2AALOX5HDAC3
SCHEMBL673384 0.83 HDAC6 (0.63) HSD17B10HDAC3HDAC4HDAC1HDAC7
SCHEMBL5232476 0.83 SRD5A2 (0.51) SRD5A2NR4A1NR4A2NR4A3MEN1
SCHEMBL8012661 0.82 CES1 (0.45) CES2CES1AKR1B1RENMEN1
SCHEMBL7656457 0.81 HDAC6 (0.60) TSHRHDAC3HDAC4HDAC1HDAC7
SCHEMBL7650749 0.81 HPGD (0.58) MEN1KMT2AHDAC1HDAC6MAPT
SCHEMBL7655904 0.81 SMN1; SMN2 (0.58) MEN1KMT2AMAPTL3MBTL1TP53
SCHEMBL8012822 0.79 CES1 (0.45) CES2CES1AKR1B1RENMEN1
SCHEMBL6929677 0.78 MAPT (0.45) NR4A2AKR1B1RENHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed